Business
Update on Morocco Pilot Trial
Update on Morocco Pilot Trial.
About this update from Quadrise Plc
[{"type":"text","content":"\n \n \n RNS Number : 1291F\n Quadrise Fuels International PLC\n 05 March 2020\n \n \n \n 5 March 2020\n \n Quadrise Fuels International plc\n (\"Quadrise\", \"QFI\" or \"the Company\")\n \n Update on Morocco Pilot Trial\n \n Quadrise is pleased to announce that significant progress has been made in preparation for the MSAR® pilot trial at one of the industrial client's sites in Morocco. \n \n Fabrication of the MSAR® pumping and heating unit ('PHU') was completed at the Quadrise Research Facility ('QRF') during February 2020 as planned. The PHU was then used to successfully complete burner tip spray testing. This testing was to ensure that Quadrise has a range of burner tips that are compatible with MSAR® fuel, in order to undertake and successfully complete the trial at the client's pilot facility and move to the next phase of the project as soon as possible. Some of the tips selected for the trial have been designed by Quadrise experts.\n \n The PHU, along with the other equipment required for the trial, and the MSAR® fuel produced at QRF, have now been shipped to Morocco and will be on site for the trial to commence in mid-March 2020 as scheduled.\n \n Three short in-house videos shot at QRF showing the production of the MSAR® used for the burner tip spray testing, the testing itself and the bulk MSAR® production for the trial in Morocco are currently being edited and will be available on the Company's website by 13 March 2020.\n \n For additional information, please contact:\n \n \n Quadrise Fuels International plc +44 (0)20 7031 7321\n Mike Kirk, Chairman\n Jason Miles, Chief Executive Officer\n \n \n FTI Consulting +44 (0)20 3727 1000\n Public and Investor Relations\n Ben Brewerton\n Ntobeko Chidavaenzi\n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For furth...